• / Free eNewsletters & Magazine
  • / My Account
Home>Authors>David Krempa

David Krempa

  1. All
  2. Morningstar Articles
  3. Videos
  1. Undervalued Valeant's Unique Strategy Is Underappreciated

    This narrow-moat pharma firm's focus on acquiring already-approved products that aren't subject to reimbursement pressure is misunderstood.

  2. 2014's Biggest Stock Winners: Is There Any Gas Left in the Tank?

    Declining fuel prices stoked great returns at several of these companies, but that's not a lasting advantage.

  3. The Friday Five

    Still gas in the tank for Apple, Facebook gets mobile mojo, a possible wide-moat combination, and more.

  4. An Undervalued Stock for Farsighted Investors

    Those with a long-term focus will earn attractive returns as the true earnings power of this firm's growth-driving product becomes apparent during the next three years.

  5. A Shift in Health-Care M&A Activity

    Recent deals have been driven more by tax strategies than therapeutic synergies.

  6. Top Holdings of Four All-Weather Ultimate Stock-Pickers

    While more than one third of these top fund managers are outperforming this year, four of them stand out from the rest given their ability to outperform the market over almost all time periods.

  7. 10 High-Conviction Purchases of Ultimate Stock-Pickers

    The pickings continue to get slimmer for a proven group of top fund managers as the market continues to trade around its all-time high.

  8. In Search of ... Recession Survivors

    Use this screen to find companies that have produced strong growth despite the recession.

  9. October/November Picks

    Four offerings deemed to be right for right now.

  10. December/January Picks

    Four offerings deemed to be right for right now.

12
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.